Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets
- 1 September 1987
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 47 (5), 561-571
- https://doi.org/10.1016/0049-3848(87)90361-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Modulation of Vascular Smooth Muscle Contraction by the EndotheliumAnnual Review of Physiology, 1986
- Cyclic guanosine monophosphate as a mediator of vasodilation.JCI Insight, 1986
- Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries.Circulation Research, 1986
- The Pharmacological and Physiological Role of Cyclic GMP in Vascular Smooth Muscle RelaxationAnnual Review of Pharmacology and Toxicology, 1985
- Species-dependent differences in the nature of endothelium-derived vascular relaxing factorEuropean Journal of Pharmacology, 1984
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- The nature of endothelium-derived vascular relaxant factorNature, 1984
- Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.Circulation Research, 1983
- The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.Circulation, 1982
- Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilatorsBlood, 1981